I had thought from reading previous announcements that the phase 3 trial did not have a placebo, but different dosage levels of the drug. I could be wrong but I think the comment was made that given every participant was to receive the drug that enrolment in the trial should not be an issue???
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.52 |
Change
-0.020(0.16%) |
Mkt cap ! $1.563B | |||
| Open | High | Low | Value | Volume |
| $12.61 | $12.68 | $12.34 | $1.942M | 155.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 347 | $12.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.53 | 464 | 4 |
View Market Depth
| Last trade - 11.07am 25/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |